We are live on
!
Find out more
VanEck Associates Portfolio holdings
AUM
$133B
1-Year Est. Return
72.99%
This Fund
S&P 500
This Quarter
Est. Return
-6.08%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$39.8B
AUM Growth
-$2.49B
(-5.9%)
Cap. Flow
+$696M
Cap. Flow
% of AUM
1.75%
Top 10 Holdings %
Top 10 Hldgs %
24.77%
Holding
1,335
New
62
Increased
793
Reduced
417
Closed
46
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$198M |
| 2 |
Synopsys
SNPS
|
+$159M |
| 3 |
Lam Research
LRCX
|
+$150M |
| 4 |
Intel
INTC
|
+$105M |
| 5 |
Western Union
WU
|
+$105M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Newmont
NEM
|
+$144M |
| 2 |
ServiceNow
NOW
|
+$108M |
| 3 |
Adobe
ADBE
|
+$108M |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$104M |
| 5 |
B
Barrick Mining
B
|
+$102M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 36.37% |
| 2 | Technology | 23.79% |
| 3 | Energy | 8.84% |
| 4 | Healthcare | 6.99% |
| 5 | Financials | 3.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Southern Company
SO
$107B
| $11.8M | 0.03% |
190,342
+15,225
| +9% | +$980K |
|
327
Zai Lab
ZLAB
$2.05B
| $11.6M | 0.03% |
110,485
-66,350
| -38% | -$9.53M |
|
328
Incyte
INCY
$24B
| $11.6M | 0.03% |
168,665
-31,467
| -16% | -$2.39M |
|
|
AESC
329
DELISTED
The AES Corporation
AESC
| $11.5M | 0.03% |
119,636
+14,176
| +13% | +$1.44M |
|
330
BioMarin Pharmaceuticals
BMRN
$11.6B
| $11.5M | 0.03% |
148,975
-24,399
| -14% | -$1.93M |
|
331
Nuveen Municipal Credit Income Fund
NZF
$2.39B
| $11.3M | 0.03% |
674,911
+14,209
| +2% | +$246K |
|
|
ADAM
332
Adamas Trust
ADAM
$848M
| $11.3M | 0.03% |
661,434
-64,725
| -9% | -$1.13M |
|
333
JD.com
JD
$44.6B
| $11.3M | 0.03% |
155,908
-18,626
| -11% | -$1.37M |
|
|
TSP
334
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
| $11.1M | 0.03% |
297,650
-2,100
| -0.7% | -$88.5K |
|
335
ArcelorMittal
MT
$54.2B
| $11M | 0.03% |
365,053
-139,952
| -28% | -$4.57M |
|
336
Carlyle Secured Lending
CGBD
$713M
| $10.9M | 0.03% |
814,125
-59,967
| -7% | -$819K |
|
337
CRISPR Therapeutics
CRSP
$4.88B
| $10.8M | 0.03% |
96,352
-7,807
| -7% | -$980K |
|
338
AT&T
T
$162B
| $10.7M | 0.03% |
526,506
-54,056
| -9% | -$1.14M |
|
339
Nucor
NUE
$59.5B
| $10.7M | 0.03% |
108,173
-43,596
| -29% | -$4.63M |
|
|
NIMC
340
DELISTED
NiSource Inc. Series A Corporate Units
NIMC
| $10.2M | 0.03% |
98,932
+11,722
| +13% | +$1.24M |
|
341
SLR Investment Corp
SLRC
$709M
| $10.1M | 0.03% |
528,727
-32,304
| -6% | -$616K |
|
|
LADR
342
Ladder Capital
LADR
$1.23B
| $10.1M | 0.03% |
915,078
-77,966
| -8% | -$872K |
|
343
Extra Space Storage
EXR
$31.6B
| $10.1M | 0.03% |
59,843
+16,163
| +37% | +$2.86M |
|
344
Bain Capital Specialty
BCSF
$824M
| $9.96M | 0.03% |
671,496
-102,999
| -13% | -$1.57M |
|
|
GLDG
345
GoldMining Inc
GLDG
$190M
| $9.94M | 0.03% |
8,498,895
-507,304
| -6% | -$650K |
|
346
Organon & Co
OGN
$3.56B
| $9.7M | 0.02% |
295,833
+106,368
| +56% | +$3.4M |
|
|
AEPPZ
347
DELISTED
American Electric Power Company, Inc. Corporate Units
AEPPZ
| $9.7M | 0.02% |
194,997
+23,106
| +13% | +$1.21M |
|
348
BlackRock Municipal 2030 Target Term Trust
BTT
$1.43B
| $9.69M | 0.02% |
379,539
+12,328
| +3% | +$323K |
|
349
Cleveland-Cliffs
CLF
$6.4B
| $9.64M | 0.02% |
486,442
-259,528
| -35% | -$5.92M |
|
350
Crown Castle
CCI
$33.5B
| $9.58M | 0.02% |
55,298
-1,454
| -3% | -$281K |
|
Similar funds
VanEck Associates's Q3 2021 Portfolio in Review
As of Q3 2021, VanEck Associates held 1,335 positions worth $39.8B, down 5.9% from $42.3B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
VanEck Associates's Q3 2021 filing shows 62 new, 793 increased, 417 reduced and 46 closed positions. Its largest new stake was Synopsys: 523,038 shares worth $157M. The largest sale was Newmont, an estimated $144M.
By sector, the portfolio is most concentrated in Materials at 36% of assets, down from 40% a quarter earlier, followed by Technology and Energy.
- VanEck Associates's largest Q3 2021 buy was Synopsys: 523,038 shares worth $157M.
- VanEck Associates added most to TSMC in Q3 2021, an estimated $198M increase.
- VanEck Associates's biggest Q3 2021 reduction was Newmont, cutting an estimated $144M.
- VanEck Associates fully exited Maxim Integrated Products in Q3 2021, selling an estimated $104M.
- VanEck Associates's ten largest holdings make up 25% of its $39.8B portfolio in Q3 2021.
- VanEck Associates opened 62 new positions and closed 46 in Q3 2021.
- VanEck Associates's portfolio value fell 5.9% quarter-over-quarter to $39.8B.
Based on VanEck Associates's 13F filing for Q3 2021, filed 3 Nov 2021.